The association between inflammation and depression was initially discovered when multiple studies found that administering IL-2 and IFN-gamma to patients triggered depressive symptoms such as anhedonia and fatigue [52,53,54,55,56,57,58]. Here, IFNG is linked to depressive symptom measurement.